ZNF296 and prostate carcinoma: This possibility is supported by our finding that Zfp296 deficiency did not affect the frequency of spontaneous tumorigenesis and lifespan; however, the role of Zfp296 loss in the pathogenesis of oligodendroglioma and prostate carcinoma in which Zfp296 is epigenetically silenced is still not known19,20.